These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36266920)
1. NBDHEX re-sensitizes adriamycin-resistant breast cancer by inhibiting glutathione S-transferase pi. Sha H; Zou R; Lu Y; Gan Y; Ma R; Feng J; Chen D Cancer Med; 2023 Mar; 12(5):5833-5845. PubMed ID: 36266920 [TBL] [Abstract][Full Text] [Related]
2. In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer. Sha H; Dong S; Yu C; Zou R; Zhu Y; Lu Y; Zhang J; Cao H; Chen D; Wu J; Feng J J Cancer; 2020; 11(24):7216-7223. PubMed ID: 33193885 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma. Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369 [TBL] [Abstract][Full Text] [Related]
5. Glutathione S-Transferase Pi is Involved in the Growth of Mice. Dong X; Rui B; Yin F; Chen D; Li L; Yin Z; Luo L Chin J Physiol; 2018 Aug; 61(4):230-239. PubMed ID: 30139245 [TBL] [Abstract][Full Text] [Related]
6. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer. Filomeni G; Turella P; Dupuis ML; Forini O; Ciriolo MR; Cianfriglia M; Pezzola S; Federici G; Caccuri AM Mol Cancer Ther; 2008 Feb; 7(2):371-9. PubMed ID: 18281520 [TBL] [Abstract][Full Text] [Related]
7. A strong glutathione S-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells. Turella P; Filomeni G; Dupuis ML; Ciriolo MR; Molinari A; De Maria F; Tombesi M; Cianfriglia M; Federici G; Ricci G; Caccuri AM J Biol Chem; 2006 Aug; 281(33):23725-32. PubMed ID: 16769721 [TBL] [Abstract][Full Text] [Related]
8. 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound. Sha HH; Wang Z; Dong SC; Hu TM; Liu SW; Zhang JY; Wu Y; Ma R; Wu JZ; Chen D; Feng JF Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29358310 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases. Federici L; Lo Sterzo C; Pezzola S; Di Matteo A; Scaloni F; Federici G; Caccuri AM Cancer Res; 2009 Oct; 69(20):8025-34. PubMed ID: 19808963 [TBL] [Abstract][Full Text] [Related]
10. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer. Su F; Hu X; Jia W; Gong C; Song E; Hamar P J Surg Res; 2003 Jul; 113(1):102-8. PubMed ID: 12943817 [TBL] [Abstract][Full Text] [Related]
11. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490 [TBL] [Abstract][Full Text] [Related]
12. Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy. Pasello M; Manara MC; Michelacci F; Fanelli M; Hattinger CM; Nicoletti G; Landuzzi L; Lollini PL; Caccuri A; Picci P; Scotlandi K; Serra M Anal Cell Pathol (Amst); 2011; 34(3):131-45. PubMed ID: 21673434 [TBL] [Abstract][Full Text] [Related]
13. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells. Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261 [TBL] [Abstract][Full Text] [Related]
14. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio) Hexanol Inhibits Proliferation and Induces Apoptosis of Endometriosis by Regulating Glutathione S-Transferase Mu Class 4. Liu W; Cheng L; Du Y; Liu X; Ma J; Yan L Reprod Sci; 2023 Oct; 30(10):2945-2961. PubMed ID: 36928896 [TBL] [Abstract][Full Text] [Related]
15. DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo. Zhang P; Zheng BB; Wang HY; Chen JH; Liu XY; Guo XL J Pharm Pharmacol; 2014 Mar; 66(3):398-407. PubMed ID: 24533823 [TBL] [Abstract][Full Text] [Related]
16. Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity. Liu Q; Liu Z; Hua W; Gou S J Med Chem; 2021 Feb; 64(3):1701-1712. PubMed ID: 33529017 [TBL] [Abstract][Full Text] [Related]
17. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876 [TBL] [Abstract][Full Text] [Related]
18. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer. Chen H; Wang X; Gou S J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264 [TBL] [Abstract][Full Text] [Related]
19. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines. Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640 [TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase P1-1 as a target for mesothelioma treatment. De Luca A; Pellizzari Tregno F; Sau A; Pastore A; Palumbo C; Alama A; Cicconi R; Federici G; Caccuri AM Cancer Sci; 2013 Feb; 104(2):223-30. PubMed ID: 23121163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]